International Duchenne Alliance Meeting Invitation, November 8, 2012, London
Posted by: Christine McSherry on October 23, 2012
Invitation to the Duchenne Alliance Meeting November 8th London
6pm – 8pm in Conference Room A, Can Mezzanine 49 -51 East Street Old Street London N1 6AH (nearest tube Old Street, Northern Line)
The Duchenne Alliance www.duchennealliance.org would like to invite a representative of your organisation to attend our next meeting that is being hosted by Action Duchenne at 6pm November 8th in London at Can Mezzanine near Old Street tube station.
As part of the pre-Action Duchenne Conference meetings www.actionduchenne.org/conference2012 in London we will be discussing the impact that the Duchenne Alliance has made so far in helping to find funding for key international research projects.
We are an alliance of independent Duchenne organisations dedicated to advancing our missions to improve quality of life, care, and treatment of those affected by Duchenne. Our goals will be achieved by building trust, sharing knowledge, leveraging resources, and streamlining business practices. Each organization will be held to achieve their own mission as we collectively serve the entire Duchenne community.
In 2011 the Alliance established an online community of non-profits and Research teams that so far has funded six projects. This is a fantastic achievement in such a short timeframe and we are now hoping that more Duchenne non-profits will join us from across the world to help continue much needed research.
We welcome ALL Duchenne foundations and non profits, large or small, to join us as we try to bring together the collective power of the Duchenne community across the globe to find new drugs, therapies and a cure for our sons.
If you would like to sign up for the Duchenne Dashboard today then please follow this link https://www.duchennedashboard.org/
If you would like to book a place at our meeting in London on November 8th or if you would like to join the webinar then please contact me by emailing email@example.com
Thank you all for your support.
Christine McSherry and Carlo Rago, PhD
Bookmark the permalink | Tagged alliance, dmd treatment, duchenne, duchenne muscular dystophy, exon skipping, international, invitation, meeting
pdufa fda patient-directed drug development patient perspectives duchenne muscular dystrophy harrison's fund duchenne allinace duchenne research alliance international invitation meeting duchenne muscular dystophy dmd treatment exon skipping sarepta eteplirsen dmd Permissible Risk Patient Perspective Duchenne Alliance PDUFA-V Fast Track Accelerated Approval Priority Review IND NDA Breakthrough therapy exon-skipping Duchenne muscular dystrophy collaboration rigorous review higher resolution. duchenne advocacy treatments pfizer children's hospital boston srpt $srpt jett foundation gower test biotech cambridge becker forbes healthcare rare disease new york times boston daily news prosensa moms morpholinos team community congress race to yes obama washington dc racetoyes washington white house petition fox business fox news stossel willis report government